What the New FDA-Approved GLP-1 Pill from Eli Lilly Means for Everyday Weight Management Options
Quick Fact List on Foundayo (orforglipron):
- Once-daily oral tablet
- Approved for chronic weight management in eligible adults
- Can be taken any time without food/water restrictions
- Works alongside diet and physical activity
- Common side effects reported in trials include nausea, diarrhea, constipation, vomiting, and in some cases hair loss (similar to the class)
- Not for everyone — talk to a healthcare provider about suitability

What This Approval Could Mean for the Weight Loss Medication Market
For complete cooking times, go to the next page or click the Open button (>), and don't forget to SHARE with your Facebook friends.